Voloridge Investment Management
REPL icon

Voloridge Investment Management’s Replimune Group REPL Stock Holding History

Voloridge Investment Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-37,534
Closed -$1.02M – 1574
2022
Q4 		$1.02M Buy
+37,534
New +$780K 0.01% 1129

Other funds holding REPL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Voloridge Investment Management's REPL Position: Q1 2023 in Review

Voloridge Investment Management sold out of Replimune Group (REPL) in Q1 2023, closing a stake of 37,534 shares — an estimated $1.02M sold.

Voloridge Investment Management first reported a position in REPL in Q4 2022 and held it in 1 quarter. The position peaked at $1.02M in Q4 2022. 140 funds tracked by Wall St. Rank hold REPL as of Q1 2023.

  • Voloridge Investment Management reported no remaining Replimune Group position as of Q1 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 37,534 Replimune Group shares in Q1 2023, an estimated $1.02M.
  • Voloridge Investment Management first reported a position in Replimune Group in Q4 2022 and held it in 1 quarter.
  • Voloridge Investment Management's Replimune Group position peaked at $1.02M in Q4 2022.
  • 140 funds tracked by Wall St. Rank held Replimune Group as of Q1 2023.

Based on Voloridge Investment Management's 13F filing for Q1 2023, filed 15 May 2023.